Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite

Vaccine

Volumn 29, Issue 40, 2011, Pages 7002-7008

  Friesen, Johannes ^a   Matuschewski, Kai ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

Malaria; Plasmodium; Sporozoite; Whole organism vaccine

Indexed keywords

AZITHROMYCIN; CD8ALPHA ANTIGEN; CHLOROQUINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MALARIA VACCINE; PRIMAQUINE; PYRIMETHAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; GAMMA IRRADIATION; IN VIVO STUDY; MALARIA CONTROL; MOUSE; NONHUMAN; PARASITE LOAD; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPOROZOITE; VACCINATION;

ANIMALS; AZITHROMYCIN; CD8-POSITIVE T-LYMPHOCYTES; CHLOROQUINE; ERYTHROCYTES; FEMALE; LIVER; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED C57BL; PARASITE LOAD; PARASITEMIA; PLASMODIUM BERGHEI; SPOROZOITES; VACCINATION; VACCINES, ATTENUATED;

EID: 80052316052     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.034     Document Type: Article

References (38)

1. Hay S.I., Okiro E.A., Gething P.W., Patil A.P., Tatem A.J., Guerra C.A., et al. Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med 2010, 7(6):e1000290.
2. Greenwood B. Malaria vaccines. Evaluation and implementation. Acta Trop 2005, 95((3) September):298-304.
3. Nussenzweig R.S., Vanderberg J., Most H., Orton C. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 1967, 216(5111):160-162.
4. Herrington D., Davis J., Nardin E., Beier M., Cortese J., Eddy H., et al. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am J Trop Med Hyg 1991, 45(5):539-547.
5. Hoffman S.L., Goh L.M., Luke T.C., Schneider I., Le T.P., Doolan D.L., et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002, 185(8):1155-1164.
6. Clyde D.F., Mccarthy V.C., Miller R.M., Woodward W.E. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 1975, 24(3):397-401.
7. Edelman R., Hoffman S.L., Davis J.R., Beier M., Sztein M.B., Losonsky G., et al. Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. J Infect Dis 1993, 168(4):1066-1070.
8. Gwadz R.W., Cochrane A.H., Nussenzweig V., Nussenzweig R.S. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ 1979, 57(Suppl. 1):165-173.
9. Hoffman S.L., Billingsley P.F., James E., Richman A., Loyevsky M., Li T., et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccine 2010, 6(1):97-106.
10. Mueller A.K., Labaied M., Kappe S.H., Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005, 433(7022):164-167.
11. Mueller A.K., Camargo N., Kaiser K., Andorfer C., Frevert U., Matuschewski K., et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A 2005, 102(8):3022-3027.
12. van Dijk M.R., Douradinha B., Franke-Fayard B., Heussler V., van Dooren M.W., van Schaijk B., et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci U S A 2005, 102(34):12194-12199.
13. van Schaijk B.C., Janse C.J., van Gemert G.J., van Dijk M.R., Gego A., Franetich J.F., et al. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PLoS One 2008, 3(10):e3549.
14. Roestenberg M., McCall M., Hopman J., Wiersma J., Luty A.J., van Gemert G.J., et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 2009, 361(5):468-477.
15. Roestenberg M., Teirlinck A.C., McCall M.B., Teelen K., Makamdop K.N., Wiersma J., et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 2011, 377(9779):1770-1776.
16. Friesen J., Silvie O., Putrianti E.D., Hafalla J.C., Matuschewski K., Borrmann S. Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med 2010, 2(40):40ra9.
17. Belnoue E., Costa F.T., Frankenberg T., Vigario A.M., Voza T., Leroy N., et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 2004, 172(4):2487-2495.
18. Friesen J., Borrmann S., Matuschewski K. Induction of anti-malaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance. Antimicrob Agents Chemother 2011, 55(6):2760-2767.
19. Putrianti E.D., Silvie O., Kordes M., Borrmann S., Matuschewski K. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 2009, 199(6):899-903.
20. Matuschewski K., Hafalla J.C., Borrmann S., Friesen J. Arrested Plasmodium liver stages as experimental anti-malaria vaccines. Hum Vaccine 2011, (Suppl. 1):16-21.
21. Silvie O., Semblat J.P., Franetich J.F., Hannoun L., Eling W., Mazier D. Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines. Parasite Immunol 2002, 24(4):221-223.
22. Hafalla J.C., Rai U., Morrot A., Bernal-Rubio D., Zavala F., Rodriguez A. Priming of CD8+ T cell responses following immunization with heat-killed Plasmodium sporozoites. Eur J Immunol 2006, 36(5):1179-1186.
23. Douradinha B., van Dijk M.R., Ataide R., van Gemert G.J., Thompson J., Franetich J.F., et al. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int J Parasitol 2007, 37(13):1511-1519.
24. Falae A., Combe A., Amaladoss A., Carvalho T., Menard R., Bhanot P. Role of Plasmodium berghei cGMP-dependent protein kinase in late liver stage development. J Biol Chem 2010, 285(5):3282-3288.
25. Mazier D., Renia L., Snounou G. A pre-emptive strike against malaria's stealthy hepatic forms. Nat Rev Drug Discov 2009, 8(11):854-864.
26. Bruna-Romero O., Hafalla J.C., Gonzalez-Aseguinolaza G., Sano G., Tsuji M., Zavala F. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int J Parasitol 2001, 31(13):1499-1502.
27. Chico R.M., Pittrof R., Greenwood B., Chandramohan D. Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J 2008, 7:255.
28. Belnoue E., Voza T., Costa F.T., Gruner A.C., Mauduit M., Rosa D.S., et al. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol 2008, 181(12):8552-8558.
29. Schmidt N.W., Butler N.S., Badovinac V.P., Harty J.T. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog 2010, 6(7):e1000998.
30. Chattopadhyay R., Conteh S., Li M., James E.R., Epstein J.E., Hoffman S.L. The effects of irradiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine. Vaccine 2009, 27(27):3675-3680.
31. Kumar K.A., Sano G., Boscardin S., Nussenzweig R.S., Nussenzweig M.C., Zavala F., et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 2006, 444(7121):937-940.
32. Suhrbier A., Winger L.A., Castellano E., Sinden R.E. Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells. Infect Immun 1990, 58(9):2834-2839.
33. Ocana-Morgner C., Mota M.M., Rodriguez A. Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med 2003, 197(2):143-151.
34. Orjih A.U., Nussenzweig R.S. Plasmodium berghei: suppression of antibody response to sporozoite stage by acute blood stage infection. Clin Exp Immunol 1979, 38(1):1-8.
35. Mueller A.K., Deckert M., Heiss K., Goetz K., Matuschewski K., Schluter D. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am J Pathol 2007, 171(1):107-115.
36. Scheller L.F., Azad A.F. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc Natl Acad Sci U S A 1995, 92(9):4066-4068.
37. Cockburn I.A., Chen Y.C., Overstreet M.G., Lees J.R., van Rooijen N., Farber D.L., et al. Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites. PLoS Pathog 2010, 6(5):e1000877.
38. Spaccapelo R., Janse C.J., Caterbi S., Franke-Fayard B., Bonilla J.A., Syphard L.M., et al. Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria. Am J Pathol 2010, 176(1):205-217.